The Spring Italian Training for AI in Drug Design (SPRINT-AIDD) is an advanced training school dedicated to the rational design of bioactive molecules and drug discovery through artificial intelligence. Now in its second edition, the school aims to provide researchers, students, and professionals with comprehensive theoretical foundations and practical expertise in the application of artificial intelligence and machine learning methodologies to medicinal chemistry, toxicology, and pharmacology. By combining lectures, hands-on sessions, and interactive discussions, SPRINT-AIDD offers participants the opportunity to deepen their understanding of cutting-edge computational approaches driving innovation in modern drug discovery.

The courses are designed for scientists actively working in the field of AI and drug discovery, with presentations delivered by senior experts from both industry and academia. Participation is limited to 25 attendees to ensure meaningful and in-depth discussions, so early registration is strongly recommended, as acceptance cannot be guaranteed for all applicants.